JP2024532403A5 - - Google Patents

Info

Publication number
JP2024532403A5
JP2024532403A5 JP2024513300A JP2024513300A JP2024532403A5 JP 2024532403 A5 JP2024532403 A5 JP 2024532403A5 JP 2024513300 A JP2024513300 A JP 2024513300A JP 2024513300 A JP2024513300 A JP 2024513300A JP 2024532403 A5 JP2024532403 A5 JP 2024532403A5
Authority
JP
Japan
Prior art keywords
ttds
group
aib
analog
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2024513300A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024532403A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/041095 external-priority patent/WO2023028008A2/en
Publication of JP2024532403A publication Critical patent/JP2024532403A/ja
Publication of JP2024532403A5 publication Critical patent/JP2024532403A5/ja
Abandoned legal-status Critical Current

Links

JP2024513300A 2021-08-23 2022-08-22 腎障害または状態の治療のためのリラキシン類似体とバソプレシン類似体との組み合わせ Abandoned JP2024532403A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163236090P 2021-08-23 2021-08-23
US63/236,090 2021-08-23
US202263332994P 2022-04-20 2022-04-20
US63/332,994 2022-04-20
PCT/US2022/041095 WO2023028008A2 (en) 2021-08-23 2022-08-22 Combination of relaxin and vasopressin analogues for treatment of renal disorders or conditions

Publications (2)

Publication Number Publication Date
JP2024532403A JP2024532403A (ja) 2024-09-05
JP2024532403A5 true JP2024532403A5 (cg-RX-API-DMAC10.html) 2025-08-29

Family

ID=85322130

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024513300A Abandoned JP2024532403A (ja) 2021-08-23 2022-08-22 腎障害または状態の治療のためのリラキシン類似体とバソプレシン類似体との組み合わせ

Country Status (7)

Country Link
US (1) US20240400638A1 (cg-RX-API-DMAC10.html)
EP (1) EP4392440A4 (cg-RX-API-DMAC10.html)
JP (1) JP2024532403A (cg-RX-API-DMAC10.html)
AU (1) AU2022334113A1 (cg-RX-API-DMAC10.html)
CA (1) CA3229783A1 (cg-RX-API-DMAC10.html)
MX (1) MX2024002335A (cg-RX-API-DMAC10.html)
WO (1) WO2023028008A2 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY199821A (en) * 2018-01-31 2023-11-23 Sanofi Sa Modified lipidated relaxin b chain peptides and their therapeutic use
WO2023086913A2 (en) 2021-11-11 2023-05-19 Tectonic Therapeutic, Inc. Relaxin-2 fusion protein analogs and methods of using same
EP4713001A2 (en) 2023-05-18 2026-03-25 Tectonic Operating Company, Inc. Relaxin-2 fusion protein analogs and methods of using same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014022294A1 (en) * 2012-07-31 2014-02-06 Novartis Ag Treating inflammation using serelaxin
SG10201912034UA (en) * 2017-02-08 2020-02-27 Bristol Myers Squibb Co Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
MY199821A (en) * 2018-01-31 2023-11-23 Sanofi Sa Modified lipidated relaxin b chain peptides and their therapeutic use

Similar Documents

Publication Publication Date Title
JP7541600B2 (ja) Gipアゴニスト化合物及び方法
KR102310389B1 (ko) Gip-glp-1 이원 효능제 화합물 및 방법
JP7295871B2 (ja) 修飾された脂質化リラキシンb鎖ペプチドおよびその治療的使用
US5932548A (en) Lysine containing peptides for treatment of heart disease
US6025471A (en) Diazaspiro, azepino and azabicyclo therapeutic peptides
JP2021512099A5 (cg-RX-API-DMAC10.html)
US20240400638A1 (en) Combination of relaxin and vasopressin analogues for treatment of renal disorders or conditions
RU2016110153A (ru) Новые пептиды и их аналоги для применения при лечении мукозита полости рта
US6124263A (en) Treatment of tumors by administration of growth hormone releasing compounds and their antagonists
TW202440165A (zh) Nmu受體2促效劑
CN1255426C (zh) 用于治疗勃起功能障碍的肽
EP0842193B1 (en) Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone
ES2291372T3 (es) Agonistas y antagonistas de urotensina-ii.
Kutina et al. Synthesis of new vasotocin analogues: effects on renal water and ion excretion in rats
JP2005082489A (ja) 新規な摂食促進ペプチド、新規な成長ホルモン分泌促進ペプチド
JP2005082489A6 (ja) 新規な摂食促進ペプチド、新規な成長ホルモン分泌促進ペプチド
JP2009502976A (ja) 親水性ペプチド鎮痛薬の経口送達のためのペプチドコンジュゲート
US20210171604A1 (en) Peptides for the treatment of type 2 diabetes
EP3253774B1 (en) Peptides for the treatment of malignant proliferative diseases
CN118510796A (zh) 用于治疗肾脏病症或疾患的松弛素和加压素类似物的组合
HK1083068A (en) Lysine containing peptides for treatment of heart disease